title: Capillary electrophoresis/frontal analysis versus equilibrium dialysis in dexamethasone sodium phosphate-serum albumin binding studies.
abstract: Plasma protein binding of drugs may have significant effect on its pharmacodynamic, toxicological and pharmacokinetic properties, since only the free drug can pass across biological membrane and get to its specific site of action. Many drugs show a high affinity to albumin which is the most abundant plasma protein. In the present study capillary electrophoresis in the frontal analysis mode (CE/FA), as promising technique for assessment of drug-protein interaction was used. The free drug concentration was measured from height of the frontal peak and calculated based on the external drug standard in absence of protein. With a known concentration of total drug, the percentage of protein bound drug was determined. The binding parameters were also estimated based on the equilibrium dialysis experiment which is considered to be a reference method. This study was designed to examine the interaction of dexamethasone sodium phosphate (DXM) with BSA and HSA under simulated physiological conditions (pH 7.4, 67 mM phosphate buffer, I = 0.17). Using fixed, at physiological level, HSA and BSA concentrations and increasing DXM concentrations, the number of binding sites (n) and binding constant (K(a) ) was calculated from both nonlinear regression fitting and Scatchard Plot. Despite some differences, it can be concluded that the CE/FA is comparable with equilibrium dialysis, but since the first one offers advantages such as low sample consumption, short analysis time, and high separation efficiency, it can be used in high-throughput screening of drug protein binding at the early stage of drug discovery. Interspecies differences in binding of a drug to albumins have been observed and it should be taken into account in interpretation of the results.
authors.affiliation: Jagiellonian Centre for Experimental Therapeutics (JCET), Jagiellonian University, Krakow, Poland.
authors.forename: Anna
authors.initials: A
authors.lastname: Gonciarz
authors.forename: Kamil
authors.initials: K
authors.lastname: Kus
authors.forename: Małgorzata
authors.initials: M
authors.lastname: Szafarz
authors.forename: Maria
authors.initials: M
authors.lastname: Walczak
authors.forename: Agnieszka
authors.initials: A
authors.lastname: Zakrzewska
authors.forename: Joanna
authors.initials: J
authors.lastname: Szymura-Oleksiak
mesh_terms: D000818:Animals; D001665:Binding Sites; D002417:Cattle; D003907:Dexamethasone / Q000031:analogs & derivatives* / Q000737:chemistry / Q000378:metabolism; D003956:Dialysis; D019075:Electrophoresis, Capillary / Q000379:methods*; D006801:Humans; D017711:Nonlinear Dynamics; D011485:Protein Binding; D012709:Serum Albumin / Q000737:chemistry* / Q000378:metabolism
chemical_list: D012709:Serum Albumin; C004180:dexamethasone 21-phosphate; D003907:Dexamethasone